Table 4.
Multivariate Analysis of Factors Associated with Overall Survival and Progression-Free Survival
| Prognostic Factors | Overall Survival | Progression-Free Survival | ||||
|---|---|---|---|---|---|---|
| HR | 95% CI | p value | HR | 95% CI | P-value | |
| T-staging (T2 vs T3+T4) | 2.397 | 0.538–10.673 | 0.251 | 2.283 | 0.735–7.088 | 0.153 |
| N-staging (N0+N1 vs N2+N3) | 1.191 | 0.703–2.021 | 0.516 | 1.023 | 0.603–1.734 | 0.933 |
| Tumor stage (II vs III) | 2.210 | 1.003–4.725 | 0.041 | 1.573 | 0.818–3.027 | 0.175 |
| NLR (≤2.07 vs >2.07) | 1.982 | 1.131–3.474 | 0.017 | 1.764 | 1.060–2.936 | 0.029 |
| PLR (≤183.06 vs >183.06) | 2.033 | 1.240–3.334 | 0.005 | 1.857 | 1.149–3.001 | 0.011 |